Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;15(2):123-36.
doi: 10.1007/s00520-006-0145-3. Epub 2006 Oct 21.

The treatment of depression in cancer patients: a systematic review

Gary Rodin  1 , Nancy Lloyd, Mark Katz, Esther Green, Jean A Mackay, Rebecca K S Wong; Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care
Affiliations

The treatment of depression in cancer patients: a systematic review

Gary Rodin et al. Support Care Cancer. 2007 Feb.

Abstract

Goals of the work: To evaluate the efficacy of pharmacological and nonpharmacological treatments for depression in cancer populations.

Materials and methods: The Supportive Care Guidelines Group conducted a systematic review of the published literature through June 2005. Search sources includes MEDLINE, EMBASE, CINAHL, PsycInfo, and the Cochrane Library. Comparative studies of treatments for depression in cancer patients were selected for review by two group members based on predefined criteria.

Main results: Seven trials of pharmacological agents and four of nonpharmacological interventions were identified. Two trials detected a significant reduction in depressive symptoms for mianserin compared with placebo, and one trial found alprazolam to be superior to progressive muscle relaxation. Four drug trials found no significant difference between groups on depression measures although posttreatment reduction of symptoms was observed for all groups in two trials comparing active treatments (fluoxetine vs desipramine and paroxetine vs amitriptyline). Of the four trials involving nonpharmacological therapies for the management of depression, two detected a benefit for treatment (a multicomponent nurse delivered intervention and an orientation program) over usual care.

Conclusion: There is limited evidence for the effectiveness of pharmacological and psychosocial interventions in the treatment of cancer patients with depressive disorders, and no evidence for the superiority of one treatment modality over another. Based on evidence from the general population and other medically ill populations, combined approaches to the treatment of depression may be the most effective. Further research is necessary in cancer patients to determine the relative effectiveness of psychosocial, pharmacological, and combined treatments.

PubMed Disclaimer

References

    1. Breast Cancer Res Treat. 2001 Nov;70(1):1-10 - PubMed
    1. J Gen Intern Med. 2001 Sep;16(9):606-13 - PubMed
    1. Can J Psychiatry. 2004 Feb;49(2):139-44 - PubMed
    1. J Clin Oncol. 2004 Jan 1;22(1):205-6; author reply 206-8 - PubMed
    1. Can J Psychiatry. 2001 Jun;46 Suppl 1:5S-90S - PubMed

Publication types

Substances